Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
16.95
+0.09 (0.53%)
Jun 12, 2026, 4:00 PM EDT - Market closed

HQL Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
198.1785.59----
Loss (Gain) From Sale of Investments
-202.92-88.97----
Other Operating Activities
44.5635.29----
Change in Accounts Receivable
-0.010.06----
Change in Other Net Operating Assets
0.02-0.26----
Operating Cash Flow
39.8131.71----
Common Dividends Paid
-33.28-31.63----
Financing Cash Flow
-39.81-31.63----
Net Cash Flow
-00.08----
Levered Free Cash Flow
-4.35-2.18----
Unlevered Free Cash Flow
-4.35-2.18----
Change in Working Capital
0.01-0.2----
SEC Filings: 10-K · 10-Q